Burkhart Schraven Selected Research

Burkhart Schraven Research Topics

Disease

9	Neoplasms (Cancer) 03/2024 - 12/2012
7	Autoimmune Diseases (Autoimmune Disease) 02/2024 - 03/2008
6	Inflammation (Inflammations) 01/2023 - 08/2007
6	Infections 12/2022 - 03/2010
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2015 - 09/2005
4	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 03/2014
3	Glioma (Gliomas) 02/2024 - 11/2020
3	Autoimmune Diseases of the Nervous System 02/2024 - 11/2020
3	Multiple Sclerosis 12/2009 - 09/2005
2	Seizures (Absence Seizure) 02/2024 - 11/2023
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 02/2024 - 11/2023
2	Venous Thrombosis (Deep-Vein Thrombosis) 03/2022 - 10/2018
2	Leukemia 01/2022 - 01/2019
2	Encephalitis (Encephalitis, Rasmussen) 11/2020 - 12/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 09/2006
2	Disease Progression 11/2013 - 05/2006
1	Asthma (Bronchial Asthma) 11/2023
1	Communicable Diseases (Infectious Diseases) 05/2023
1	Human Influenza (Influenza) 05/2023
1	Hypoxia (Hypoxemia) 01/2023
1	COVID-19 12/2022
1	Polycythemia Vera 05/2022
1	Thromboinflammation 03/2022
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2022
1	Rheumatoid Arthritis 02/2022
1	Celiac Disease (Celiac Sprue) 02/2022
1	Hypersensitivity (Allergy) 01/2022
1	Contact Dermatitis (Eczema, Contact) 01/2021
1	Neuroinflammatory Diseases 11/2020
1	Meningoencephalitis 11/2020
1	Paralysis (Palsy) 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Thrombosis (Thrombus) 10/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Peritonitis 05/2015
1	Immune System Diseases (Immune Disorders) 03/2014

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2015
4	Peptides (Polypeptides)IBA 05/2023 - 04/2007
4	CytokinesIBA 01/2023 - 09/2005
4	IntegrinsIBA 03/2022 - 08/2007
4	Memantine (Namenda)FDA Link 01/2019 - 03/2014
3	Leucine (L-Leucine)FDA Link 02/2024 - 11/2020
3	AutoantibodiesIBA 11/2023 - 02/2022
3	Tyrosine (L-Tyrosine)FDA Link 03/2010 - 06/2005
2	Immunoglobulin E (IgE)IBA 11/2023 - 12/2022
2	AntigensIBA 05/2023 - 01/2017
2	ZincIBA 05/2023 - 01/2022
2	zinc aspartateIBA 05/2023 - 03/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2022
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 12/2022 - 02/2022
2	AntibodiesIBA 11/2020 - 10/2018
1	Thrombopoietin (c-mpl Ligand)IBA 03/2024
1	CalciumIBA 03/2024
1	Erythropoietin FDA Link 03/2024
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 02/2024
1	Interleukin-10 (Interleukin 10)IBA 02/2024
1	AllergensIBA 11/2023
1	Hypoxia-Inducible Factor 1IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	KynurenineIBA 01/2023
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2023
1	Interleukin-13IBA 12/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 05/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 05/2022
1	COVID-19 VaccinesIBA 02/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 08/2021
1	pitavastatin (itavastatin)FDA Link 07/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Amine Oxidase (Copper-Containing)IBA 01/2020
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 07/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	Potassium Channels (Potassium Channel)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2019
1	Cytochromes c (Cytochrome c)IBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Caspase 9IBA 01/2019
1	PerforinIBA 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2015
1	Fc Receptors (Fc Receptor)IBA 05/2015
1	Ketamine FDA LinkGeneric 12/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2014
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2012
1	lime (calcium oxide)FDA Link 03/2010
1	GRB2 Adaptor ProteinIBA 03/2010
1	CannabinoidsIBA 12/2009

Therapy/Procedure

6	Therapeutics 05/2023 - 08/2016
3	Immunotherapy 01/2023 - 07/2019
2	Aftercare (After-Treatment) 11/2020 - 01/2019
1	Transplantation 01/2017
1	Immunomodulation 08/2016
1	Ligation 12/2012